Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
RENB
Shares outstanding
226,664,950
Price per share
$0.88
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5
Total reported value
$7
% of total 13F portfolios
0%
Share change
-14,418,363
Value change
-$4,165,692
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
William Anderson Wittekind 8% -24% $6,165,287 18,133,196 0% William Anderson Wittekind 09 Jul 2025

As of 30 Sep 2025, 1 institutional investors reported holding 5 shares of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB). This represents 0% of the company’s total 226,664,950 outstanding shares.

Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 473 $417 +$410 $0.88 1
2025 Q3 5 $7 -$4,165,692 $1.40 1
2025 Q2 14,426,097 $4,167,462 -$2,600,850 $0.29 41
2025 Q1 22,011,689 $11,956,410 -$181,223 $0.54 60
2024 Q4 22,130,549 $18,494,153 +$6,146,126 $0.84 57
2024 Q3 14,761,228 $7,133,271 +$169,023 $0.48 49
2024 Q2 14,157,443 $24,775,638 +$11,117,463 $1.75 38
2024 Q1 7,245,406 $19,200,126 +$12,235,433 $2.65 40
2023 Q4 15,000 $47,550 $3.17 1
2023 Q3 1,488,192 $6,652,555 +$1,218,445 $4.47 20
2023 Q2 1,646,247 $932,527 -$1,060,543 $0.57 27
2023 Q1 3,302,827 $3,021,918 -$315,474 $0.92 39
2022 Q4 3,630,699 $3,739,109 -$209,568 $1.03 38
2022 Q3 3,769,552 $6,822,610 -$302,577 $1.81 34
2022 Q2 3,939,159 $7,601,528 +$129,203 $1.93 45
2022 Q1 2,604,770 $21,490,710 +$1,364,264 $8.25 41
2021 Q4 2,319,440 $16,905,948 +$6,892,254 $7.29 38
2021 Q3 1,518,887 $10,220,969 -$6,805,451 $6.73 29
2021 Q2 2,668,803 $13,264,326 +$150,079 $4.97 31
2021 Q1 2,712,984 $9,596,672 +$1,002,016 $3.54 40
2020 Q4 2,443,412 $7,214,222 +$130,902 $2.95 38
2020 Q3 2,380,458 $8,534,220 -$333,550 $3.58 35
2020 Q2 2,461,268 $10,364,463 +$787,785 $4.21 30
2020 Q1 2,283,856 $6,848,756 +$392,627 $3.00 29
2019 Q4 2,147,093 $10,777,417 +$4,874,418 $5.02 33
2019 Q3 1,168,546 $6,424,078 -$53,010 $5.50 28
2019 Q2 1,155,541 $5,198,567 +$1,036,624 $4.50 26
2019 Q1 892,837 $6,194,000 +$6,173,030 $6.94 17
2018 Q4 2,941 $21,000 +$21,000 $7.11 2